No discrete host molecular drug target

The classification 'No discrete host molecular drug target' refers to a group of therapeutic agents that do not interact with specific human proteins, such as receptors, enzymes, or transporters, to achieve their clinical effect (DrugBank, 2024). Instead, these drugs typically function through physicochemical mechanisms. For example, antacids like aluminum hydroxide work by chemically neutralizing gastric acid, while osmotic diuretics like mannitol create physical pressure gradients to facilitate fluid movement (StatPearls, 2023). Chelating agents such as edetate calcium disodium act by sequestering metal ions, and activated charcoal works through physical adsorption of toxins in the gastrointestinal tract (PubChem, 2024). This category also encompasses drugs that target non-host molecules, such as the cell walls or enzymes of invading pathogens like bacteria and viruses (IUPHAR/BPS Guide to Pharmacology, 2023). Because these agents do not rely on specific host molecular binding, their therapeutic index is often determined by their chemical concentration and physical properties rather than receptor-ligand kinetics.

Other names

Non-molecular targetNon-specific targetPhysicochemical mechanismPathogen-specific target

Physicochemical mechanisms including chemical neutralization, osmotic gradient formation, metal ion chelation, surfactant action, and physical adsorption (DrugBank, 2024; StatPearls, 2023).